SeaStar Medical Holding Corp
corporate_fare Company Profile
SeaStar Medical Holding Corp (NASDAQ:ICU) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 25 items for ICU at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-20, rated 8/10. Across its 20 most recent items scored 7 or higher, the top rating is 8/10, with 10 rated 8 or above. Recent SEC coverage for ICU spans 8-K, 10-Q, 8-K/A, 424B3.
Recent high-impact activity:
- SeaStar Medical Hit With Nasdaq Deficiency Notice on $2.5M Equity Rule
- SeaStar 10-Q: Q3 Revenue Up 247% to $635K, But Going Concern Flags $3.99M Cash
- SeaStar Q3 Revenue Up 247% but NEUTRALIZE-AKI Enrollment Slips to Mid-2027
- SeaStar Medical Posts $4.5M Q3 Net Loss as Operating Expenses Hit $5.2M
- FDA Clears QUELIMMUNE Post-Approval Study Requirement, Opening Therapy to More Pediatric Centers
Financial Snapshot
Short Interest & Short Volume
1.33 days to coverFINRA reported short interest of 175,168 shares in ICU as of the October 30, 2026 settlement, a 5.7% decrease from the prior period — about 1.3 days to cover at its recent average daily volume. On November 20, 2026, 36.3% of ICU volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Dilution Risk
Low riskFiling-implied dilution signals for ICU, detected from its recent SEC filings · based on capital-structure filings through 2026-10-30.
Resale Registration of Inducement Warrants · No Proceeds From Resales
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →